Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-27

Clinical Trial Update: Efficacy and Safety of Filgrastim in Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the efficacy and safety of filgrastim in Alzheimer's disease. Results were posted in December 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Filgrastim (filgrastim)

Snippet

Sponsor: University of South Florida | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-12-27